Concepts (241)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcium | 32 | 2019 | 191 | 2.550 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 32 | 2019 | 70 | 2.510 |
Why?
|
| Calcium Channels | 25 | 2002 | 73 | 1.830 |
Why?
|
| Sarcoplasmic Reticulum | 25 | 2018 | 112 | 1.360 |
Why?
|
| Animals | 44 | 2018 | 760 | 0.890 |
Why?
|
| Myocardium | 10 | 2016 | 46 | 0.840 |
Why?
|
| Muscle Proteins | 9 | 1997 | 15 | 0.710 |
Why?
|
| Calcium Signaling | 6 | 2019 | 62 | 0.630 |
Why?
|
| Ion Channel Gating | 13 | 2017 | 52 | 0.620 |
Why?
|
| Muscles | 11 | 1994 | 40 | 0.610 |
Why?
|
| Peptides | 1 | 2016 | 16 | 0.520 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 28 | 0.510 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2019 | 15 | 0.480 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 7 | 2000 | 9 | 0.450 |
Why?
|
| Receptors, Cholinergic | 7 | 1993 | 8 | 0.330 |
Why?
|
| Humans | 12 | 2019 | 2066 | 0.300 |
Why?
|
| Calmodulin | 2 | 2019 | 5 | 0.300 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 2 | 2018 | 2 | 0.300 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2018 | 9 | 0.300 |
Why?
|
| Muscle Contraction | 6 | 2000 | 37 | 0.280 |
Why?
|
| Mutation, Missense | 2 | 2017 | 5 | 0.270 |
Why?
|
| Adaptation, Physiological | 4 | 2002 | 17 | 0.260 |
Why?
|
| Myocytes, Cardiac | 3 | 2018 | 35 | 0.230 |
Why?
|
| Models, Biological | 5 | 2018 | 101 | 0.220 |
Why?
|
| Magnesium | 3 | 2016 | 19 | 0.220 |
Why?
|
| Lipid Bilayers | 12 | 2016 | 29 | 0.220 |
Why?
|
| Heart | 4 | 2016 | 14 | 0.220 |
Why?
|
| Dogs | 9 | 2002 | 57 | 0.220 |
Why?
|
| Cytoplasm | 2 | 2003 | 12 | 0.210 |
Why?
|
| Intracellular Fluid | 1 | 2003 | 1 | 0.210 |
Why?
|
| Membrane Potentials | 12 | 2016 | 88 | 0.200 |
Why?
|
| Malignant Hyperthermia | 3 | 1993 | 7 | 0.200 |
Why?
|
| Caffeine | 7 | 2002 | 25 | 0.200 |
Why?
|
| Mutation | 2 | 2019 | 64 | 0.200 |
Why?
|
| In Vitro Techniques | 10 | 2002 | 67 | 0.200 |
Why?
|
| Kinetics | 13 | 2000 | 61 | 0.190 |
Why?
|
| Ryanodine | 9 | 2002 | 14 | 0.190 |
Why?
|
| Acetates | 3 | 1997 | 3 | 0.190 |
Why?
|
| Ethylenediamines | 3 | 1997 | 3 | 0.190 |
Why?
|
| Heart Rate | 2 | 2016 | 13 | 0.170 |
Why?
|
| Microsomes | 7 | 2000 | 9 | 0.160 |
Why?
|
| Rabbits | 10 | 2018 | 52 | 0.150 |
Why?
|
| Calcium Channel Blockers | 3 | 2003 | 13 | 0.150 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 5 | 2000 | 7 | 0.150 |
Why?
|
| Heart Atria | 1 | 2018 | 1 | 0.150 |
Why?
|
| Chelating Agents | 2 | 1997 | 6 | 0.150 |
Why?
|
| Atrial Fibrillation | 1 | 2018 | 8 | 0.150 |
Why?
|
| HEK293 Cells | 4 | 2019 | 10 | 0.140 |
Why?
|
| Chlorides | 2 | 2016 | 8 | 0.140 |
Why?
|
| Potassium | 1 | 2016 | 11 | 0.140 |
Why?
|
| Nebivolol | 1 | 2016 | 1 | 0.130 |
Why?
|
| Scorpion Venoms | 1 | 2016 | 1 | 0.130 |
Why?
|
| Photolysis | 4 | 1997 | 4 | 0.130 |
Why?
|
| Cesium | 4 | 1999 | 5 | 0.120 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 7 | 2000 | 8 | 0.110 |
Why?
|
| Mice | 4 | 2018 | 219 | 0.110 |
Why?
|
| Heart Ventricles | 4 | 2000 | 20 | 0.090 |
Why?
|
| Antibodies | 1 | 1991 | 11 | 0.090 |
Why?
|
| Binding Sites | 3 | 2019 | 12 | 0.090 |
Why?
|
| Calcium Channels, L-Type | 3 | 2019 | 20 | 0.090 |
Why?
|
| Muscle, Skeletal | 3 | 2002 | 69 | 0.090 |
Why?
|
| Permeability | 3 | 1999 | 9 | 0.090 |
Why?
|
| Patch-Clamp Techniques | 3 | 2002 | 43 | 0.090 |
Why?
|
| Adenosine Triphosphate | 4 | 2002 | 10 | 0.090 |
Why?
|
| Sodium Compounds | 1 | 1990 | 4 | 0.090 |
Why?
|
| Perchlorates | 1 | 1990 | 5 | 0.090 |
Why?
|
| Cell Line | 3 | 2018 | 50 | 0.080 |
Why?
|
| Ion Channels | 6 | 1999 | 52 | 0.080 |
Why?
|
| Amino Acid Sequence | 5 | 2000 | 19 | 0.080 |
Why?
|
| Molecular Sequence Data | 5 | 2000 | 23 | 0.080 |
Why?
|
| Recombinant Proteins | 5 | 2000 | 33 | 0.080 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2 | 2019 | 7 | 0.080 |
Why?
|
| Myocardial Contraction | 2 | 2016 | 19 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 1999 | 2 | 0.070 |
Why?
|
| Ligands | 3 | 1999 | 9 | 0.070 |
Why?
|
| Male | 4 | 2018 | 1130 | 0.070 |
Why?
|
| Algorithms | 2 | 2016 | 41 | 0.070 |
Why?
|
| Signal Transduction | 2 | 1998 | 71 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2018 | 90 | 0.070 |
Why?
|
| Action Potentials | 3 | 2004 | 33 | 0.070 |
Why?
|
| Barium | 2 | 1999 | 7 | 0.070 |
Why?
|
| Electrophysiology | 3 | 1999 | 52 | 0.070 |
Why?
|
| Potassium Channels | 3 | 2018 | 14 | 0.060 |
Why?
|
| Arsenazo III | 1 | 1986 | 1 | 0.060 |
Why?
|
| Azo Compounds | 1 | 1986 | 1 | 0.060 |
Why?
|
| COS Cells | 3 | 2000 | 5 | 0.060 |
Why?
|
| Ions | 3 | 2016 | 15 | 0.060 |
Why?
|
| Rats | 6 | 2004 | 160 | 0.060 |
Why?
|
| Strontium | 1 | 2004 | 1 | 0.060 |
Why?
|
| Cations, Divalent | 1 | 2004 | 2 | 0.060 |
Why?
|
| Swine | 3 | 1993 | 8 | 0.050 |
Why?
|
| Reference Values | 3 | 1993 | 22 | 0.050 |
Why?
|
| Feedback | 1 | 2002 | 10 | 0.050 |
Why?
|
| Intracellular Membranes | 4 | 1998 | 9 | 0.050 |
Why?
|
| Protein Binding | 2 | 2019 | 22 | 0.050 |
Why?
|
| Receptors, Cell Surface | 2 | 1993 | 4 | 0.050 |
Why?
|
| Electric Conductivity | 4 | 1996 | 42 | 0.050 |
Why?
|
| Daunorubicin | 1 | 2000 | 1 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2000 | 3 | 0.050 |
Why?
|
| Reaction Time | 1 | 2000 | 25 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 2 | 1999 | 10 | 0.040 |
Why?
|
| Cerebellum | 2 | 1998 | 7 | 0.040 |
Why?
|
| Binding, Competitive | 3 | 2000 | 5 | 0.040 |
Why?
|
| Receptors, Nicotinic | 2 | 1990 | 3 | 0.040 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1999 | 1 | 0.040 |
Why?
|
| Rana pipiens | 2 | 1990 | 45 | 0.040 |
Why?
|
| Plasmids | 1 | 1999 | 10 | 0.040 |
Why?
|
| Gene Deletion | 1 | 1999 | 9 | 0.040 |
Why?
|
| Diffusion | 1 | 1999 | 11 | 0.040 |
Why?
|
| Biophysical Phenomena | 2 | 1998 | 15 | 0.040 |
Why?
|
| Apoptosis | 1 | 1999 | 32 | 0.040 |
Why?
|
| Biophysics | 2 | 1998 | 19 | 0.040 |
Why?
|
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 1998 | 1 | 0.040 |
Why?
|
| Calcium Channel Agonists | 1 | 1998 | 1 | 0.040 |
Why?
|
| Heat-Shock Proteins | 1 | 1998 | 1 | 0.040 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 1998 | 2 | 0.040 |
Why?
|
| Stochastic Processes | 1 | 1998 | 6 | 0.040 |
Why?
|
| Electrochemistry | 2 | 1997 | 11 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 1998 | 11 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 1998 | 23 | 0.040 |
Why?
|
| Osmolar Concentration | 2 | 1997 | 8 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 2 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 4 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 8 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 7 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2018 | 17 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2018 | 4 | 0.040 |
Why?
|
| Female | 2 | 2018 | 1048 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2018 | 25 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 1997 | 26 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 27 | 0.040 |
Why?
|
| Systole | 1 | 2018 | 2 | 0.040 |
Why?
|
| Age Factors | 1 | 2018 | 54 | 0.040 |
Why?
|
| Diastole | 1 | 2018 | 12 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 57 | 0.040 |
Why?
|
| Indicators and Reagents | 1 | 1997 | 4 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 1997 | 7 | 0.040 |
Why?
|
| Aging | 1 | 2018 | 79 | 0.040 |
Why?
|
| Protein Conformation | 4 | 1999 | 21 | 0.040 |
Why?
|
| Diazonium Compounds | 1 | 1997 | 1 | 0.030 |
Why?
|
| Phenoxyacetates | 1 | 1997 | 1 | 0.030 |
Why?
|
| Phospholipids | 1 | 1997 | 4 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2017 | 1 | 0.030 |
Why?
|
| Protein Domains | 1 | 2016 | 1 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2016 | 3 | 0.030 |
Why?
|
| Cytosol | 1 | 2017 | 23 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2016 | 2 | 0.030 |
Why?
|
| Adrenergic beta-1 Receptor Agonists | 1 | 2016 | 1 | 0.030 |
Why?
|
| Carbazoles | 1 | 2016 | 2 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2016 | 3 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 2016 | 2 | 0.030 |
Why?
|
| Propanolamines | 1 | 2016 | 2 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2016 | 4 | 0.030 |
Why?
|
| Putrescine | 1 | 1996 | 1 | 0.030 |
Why?
|
| Spermidine | 1 | 1996 | 1 | 0.030 |
Why?
|
| Spermine | 1 | 1996 | 1 | 0.030 |
Why?
|
| Tachycardia, Ventricular | 1 | 2016 | 4 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2016 | 9 | 0.030 |
Why?
|
| Endoplasmic Reticulum, Smooth | 1 | 1996 | 1 | 0.030 |
Why?
|
| Aged | 1 | 2018 | 461 | 0.030 |
Why?
|
| Middle Aged | 1 | 2018 | 544 | 0.030 |
Why?
|
| Time Factors | 3 | 2004 | 149 | 0.030 |
Why?
|
| Adult | 1 | 2018 | 602 | 0.030 |
Why?
|
| Transfection | 3 | 2000 | 19 | 0.030 |
Why?
|
| Cell Fractionation | 1 | 1994 | 2 | 0.030 |
Why?
|
| Surface Properties | 1 | 1994 | 17 | 0.030 |
Why?
|
| Chloride Channels | 2 | 1991 | 3 | 0.030 |
Why?
|
| Membrane Proteins | 2 | 1991 | 12 | 0.030 |
Why?
|
| Models, Chemical | 2 | 1997 | 19 | 0.020 |
Why?
|
| Species Specificity | 1 | 1991 | 8 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 1991 | 2 | 0.020 |
Why?
|
| Epitopes | 1 | 1991 | 3 | 0.020 |
Why?
|
| Histological Techniques | 1 | 1990 | 2 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 1990 | 2 | 0.020 |
Why?
|
| Oxadiazoles | 1 | 1989 | 1 | 0.020 |
Why?
|
| Alkaloids | 1 | 1989 | 3 | 0.020 |
Why?
|
| Nitrendipine | 1 | 1989 | 2 | 0.020 |
Why?
|
| Gallopamil | 1 | 1989 | 6 | 0.020 |
Why?
|
| Temperature | 1 | 1989 | 11 | 0.020 |
Why?
|
| Cell Membrane | 1 | 1989 | 35 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 1988 | 2 | 0.020 |
Why?
|
| Fluorescent Dyes | 2 | 2000 | 15 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1988 | 13 | 0.020 |
Why?
|
| Ferrets | 2 | 1998 | 3 | 0.020 |
Why?
|
| Base Sequence | 2 | 1998 | 18 | 0.020 |
Why?
|
| bcl-X Protein | 2 | 1999 | 2 | 0.020 |
Why?
|
| Absorption | 1 | 1986 | 2 | 0.020 |
Why?
|
| Rana temporaria | 1 | 1986 | 5 | 0.020 |
Why?
|
| Drug Interactions | 1 | 1986 | 7 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 1986 | 4 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 47 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 69 | 0.010 |
Why?
|
| Tritium | 2 | 1993 | 3 | 0.010 |
Why?
|
| Sulfhydryl Reagents | 1 | 2000 | 1 | 0.010 |
Why?
|
| Dithiothreitol | 1 | 2000 | 2 | 0.010 |
Why?
|
| Proteolipids | 1 | 2000 | 1 | 0.010 |
Why?
|
| Dihydropyridines | 2 | 1991 | 5 | 0.010 |
Why?
|
| Anura | 1 | 2000 | 13 | 0.010 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2000 | 3 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2000 | 23 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2000 | 15 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2000 | 16 | 0.010 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2000 | 26 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1999 | 1 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 1999 | 1 | 0.010 |
Why?
|
| Dimerization | 1 | 1999 | 2 | 0.010 |
Why?
|
| Cell Survival | 1 | 1999 | 13 | 0.010 |
Why?
|
| Models, Molecular | 1 | 1999 | 14 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 1998 | 1 | 0.010 |
Why?
|
| Sarcolemma | 1 | 1998 | 3 | 0.010 |
Why?
|
| DNA Primers | 1 | 1998 | 9 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1998 | 9 | 0.010 |
Why?
|
| Heparin | 1 | 1998 | 4 | 0.010 |
Why?
|
| Cattle | 1 | 1998 | 14 | 0.010 |
Why?
|
| Ribonucleases | 1 | 1997 | 1 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1997 | 5 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 10 | 0.010 |
Why?
|
| Organic Chemicals | 1 | 1997 | 1 | 0.010 |
Why?
|
| Buffers | 1 | 1997 | 4 | 0.010 |
Why?
|
| Fluorescence | 1 | 1997 | 4 | 0.010 |
Why?
|
| Photic Stimulation | 1 | 1997 | 6 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1997 | 39 | 0.010 |
Why?
|
| Forecasting | 1 | 1997 | 10 | 0.010 |
Why?
|
| Cations | 1 | 1997 | 3 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1997 | 4 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 1997 | 15 | 0.010 |
Why?
|
| Chickens | 1 | 1996 | 3 | 0.010 |
Why?
|
| Mammals | 1 | 1996 | 3 | 0.010 |
Why?
|
| Isomerism | 1 | 1993 | 1 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1993 | 1 | 0.010 |
Why?
|
| Calcium Radioisotopes | 1 | 1993 | 2 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 1993 | 4 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 1993 | 7 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1993 | 8 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1989 | 1 | 0.010 |
Why?
|
| Isradipine | 1 | 1989 | 2 | 0.010 |
Why?
|
| Membranes | 1 | 1989 | 6 | 0.010 |
Why?
|
| Alcohols | 1 | 1988 | 1 | 0.000 |
Why?
|
| Tromethamine | 1 | 1988 | 1 | 0.000 |
Why?
|
| Ruthenium Red | 1 | 1988 | 6 | 0.000 |
Why?
|
| Solutions | 1 | 1988 | 7 | 0.000 |
Why?
|